- Home
- SYRE vs CBZ Comparison
SYRE vs CBZ Comparison
Compare SYRE & CBZ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | SYRE | CBZ |
|---|---|---|
| Founded | 2013 | 1987 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Business Services |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.6B | 2.7B |
| IPO Year | 2016 | N/A |
Fundamental Metrics
Financial Performance| Metric | SYRE | CBZ |
|---|---|---|
| Price | $33.30 | $50.78 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 6 | 1 |
| Target Price | $56.50 | ★ $60.00 |
| AVG Volume (30 Days) | ★ 795.0K | 483.1K |
| Earning Date | 02-26-2026 | 02-25-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ 1.66 |
| Revenue | N/A | ★ $2,675,607,000.00 |
| Revenue This Year | N/A | $55.61 |
| Revenue Next Year | N/A | $6.17 |
| P/E Ratio | ★ N/A | $30.64 |
| Revenue Growth | N/A | ★ 59.19 |
| 52 Week Low | $10.91 | $47.89 |
| 52 Week High | $35.31 | $90.13 |
Technical Indicators
Market Signals| Indicator | SYRE | CBZ |
|---|---|---|
| Relative Strength Index (RSI) | 58.08 | 42.02 |
| Support Level | $30.00 | $53.25 |
| Resistance Level | $34.21 | $54.45 |
| Average True Range (ATR) | 1.83 | 1.68 |
| MACD | -0.02 | -0.23 |
| Stochastic Oscillator | 84.46 | 18.15 |
Price Performance
Historical ComparisonAbout SYRE Spyre Therapeutics Inc.
Spyre Therapeutics Inc is a biotechnology company that aims to create the next-generation of inflammatory bowel disease (IBD) products by combining antibody engineering, rational therapeutic combinations, and precision medicine approaches for patient selection. IBD is a chronic condition characterized by inflammation within the gastrointestinal tract, including two main disorders which are UC and CD. It has a single reportable segment, which is the development of biopharmaceutical products for the treatment of patients with IBD and other immune-mediated disease.
About CBZ CBIZ Inc.
CBIZ Inc through its subsidiaries provides professional services advisors to middle-market businesses and organizations nationwide. Its business units have been aggregated into three practice groups: Financial Services, Benefits and Insurance Services, and National Practices. The company provides its services to various industries such as Banking & Financial Services, Commercial Real Estate, Construction, Health Care Manufacturing & Distribution NFP & Education, Private Client Services, Professional Services, Public Sector, and Technology & Life Sciences. It derives the majority of its revenues from the Financial Services segment and geographically from the United States.